Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclylmethyl-thienouracile as antagonists of the adenosine-A2B-receptor

Heterocyclylmethyl-thienouracile as antagonists of the adenosine-A2B-receptor

US Patent 10428083 · Granted Oct 1, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted aminoquinolones as dgkalpha inhibitors for immune activation2025
Substituted hydantoinamides as ADAMTS7 antagonists2025
Diazabicyclic substituted imidazopyrimidines and their use for the treatment of 2024
Diazabicyclic substituted imidazopyrimidines and their use for the treatment of 2024
Active compound combinations containing a thiazoylisoxazoline and a fungicide2024
Substituted aminoquinolones as DGKalpha inhibitors for immune activation2024
Substituted S-alaninate derivatives2024
Amine substituted triazole derivatives and uses thereof2022
Amine substituted triazole derivatives and uses thereof2022
Prodrugs of substituted triazole derivatives and uses thereof2022
Prodrugs of substituted triazole derivatives and uses thereof2022
Substituted triazole derivatives and uses thereof2022